Search Clinical Trials
583,695 trials
ID
Status
Phase
Title
Sponsor
NCT07576725
Low Dose, Reduced Frequency Nivolumab for the Treatment of Unresectable or Metastatic Cancer, AFFORD IO TrialFred Hutchinson Cancer CenterNot Yet RecruitingPhase 2
NCT07576725Not Yet Recruiting
Phase 2
Low Dose, Reduced Frequency Nivolumab for the Treatment of Unresectable or Metas...Fred Hutchinson Cancer Ce...
NCT07574593
NORM-HF Pivotal StudyBaim Institute for Clinical ResearchNot Yet RecruitingNot Applicable
NCT07575334
Acupuncture Therapy for Sudden Sensorineural Hearing LossEye & ENT Hospital of Fudan UniversityRecruitingNot Applicable
NCT07575334Recruiting
Not Applicable
Acupuncture Therapy for Sudden Sensorineural Hearing LossEye & ENT Hospital of Fud...
NCT07576595
Multilevel Intervention for LDCT Lung Cancer Screening and Smoking Cessation Among African AmericansLouisiana State University Health Sciences Center in New OrleansRecruitingNot Applicable
NCT07576595Recruiting
Not Applicable
Multilevel Intervention for LDCT Lung Cancer Screening and Smoking Cessation Amo...Louisiana State Universit...
NCT07574918
Measuring Nasal Airway Changes After VivAer Treatment Using AI Analysis.Aerin MedicalNot Yet RecruitingNot Applicable
NCT07574918Not Yet Recruiting
Not Applicable
Measuring Nasal Airway Changes After VivAer Treatment Using AI Analysis.Aerin Medical
NCT07576569
Nursing Intervention for Adaptation After Myocardial RevascularizationUniversidad de la SabanaNot Yet RecruitingNot Applicable
NCT07576569Not Yet Recruiting
Not Applicable
Nursing Intervention for Adaptation After Myocardial RevascularizationUniversidad de la Sabana
NCT07575776
Effect of High-Flow Nasal Oxygen on Laryngoscopic ViewMasarykova Nemocnice v Usti nad Labem, Krajska Zdravotni a.s.Not Yet Recruiting
NCT07575776Not Yet Recruiting
—
Effect of High-Flow Nasal Oxygen on Laryngoscopic ViewMasarykova Nemocnice v Us...
NCT07576010
Steroids Combined With Ruxolitinib as First-Line Therapy for Grade II Acute Graft-versus-Host DiseaseDaihong LiuActive Not RecruitingPhase 1
NCT07576010Active Not Recruiting
Phase 1
Steroids Combined With Ruxolitinib as First-Line Therapy for Grade II Acute Graf...Daihong Liu
NCT07576491
Correlation Between Toilet Sitting Position, Ankle Range of Motion, and Lower Limb Strength in ChildrenRiphah International UniversityRecruiting
NCT07576491Recruiting
—
Correlation Between Toilet Sitting Position, Ankle Range of Motion, and Lower Li...Riphah International Univ...
NCT07575113
Comparison of Otago and Beat it Program on Balance, Gait and QOL in Diabetic NeuropathyRiphah International UniversityNot Yet RecruitingNot Applicable
NCT07575113Not Yet Recruiting
Not Applicable
Comparison of Otago and Beat it Program on Balance, Gait and QOL in Diabetic Neu...Riphah International Univ...
NCT07575880
Screening for Obstructive Respiratory Disorders in the General Population During the "Mai Poumon 2026" Prevention Campaign: Prevalence and Impact on the Care PathwayCentre Hospitalier de la côte BasqueNot Yet Recruiting
NCT07575880Not Yet Recruiting
—
Screening for Obstructive Respiratory Disorders in the General Population During...Centre Hospitalier de la...
NCT07576673
Self-Cure vs. Highly Filled Flowable Composite in Carious Cervical Lesions: 18-Month RCTCairo UniversityNot Yet RecruitingNot Applicable
NCT07576673Not Yet Recruiting
Not Applicable
Self-Cure vs. Highly Filled Flowable Composite in Carious Cervical Lesions: 18-M...Cairo University
NCT07576283
Comparative Effects of Hypopressive and Transverses Abdominis Focused Core Training in PostpartumRiphah International UniversityRecruitingNot Applicable
NCT07576283Recruiting
Not Applicable
Comparative Effects of Hypopressive and Transverses Abdominis Focused Core Train...Riphah International Univ...
NCT07576647
Optimized Recruitment to Drive Equitable Research in Stroke, Empowering Decision-making (ORDERed)McMaster UniversityNot Yet RecruitingNot Applicable
NCT07576647Not Yet Recruiting
Not Applicable
Optimized Recruitment to Drive Equitable Research in Stroke, Empowering Decision...McMaster University
NCT07575581
Psychometric Evaluation of the EVARUCI Scale in Turkish Intensive Care UnitsIstanbul UniversityCompleted
NCT07575581Completed
—
Psychometric Evaluation of the EVARUCI Scale in Turkish Intensive Care UnitsIstanbul University
NCT07574762
Total Knee Arthroplasty With Personalized Implantation: Computer Navigation-Assisted Surgery Versus Robotic-Assisted SurgeryGroupe Hospitalier Diaconesses Croix Saint-SimonRecruitingNot Applicable
NCT07574762Recruiting
Not Applicable
Total Knee Arthroplasty With Personalized Implantation: Computer Navigation-Assi...Groupe Hospitalier Diacon...
NCT07576842
Testing the Feasibility of Different HPV Screening and Care Strategies for Women Living With HIVBeth Israel Deaconess Medical CenterNot Yet RecruitingNot Applicable
NCT07576842Not Yet Recruiting
Not Applicable
Testing the Feasibility of Different HPV Screening and Care Strategies for Women...Beth Israel Deaconess Med...
NCT07575438
Effects of Different Fish Oil Types on Type 2 Diabetes Risk Factors in High-Risk AdultsDiabetes CanadaNot Yet RecruitingPhase 2
NCT07575438Not Yet Recruiting
Phase 2
Effects of Different Fish Oil Types on Type 2 Diabetes Risk Factors in High-Risk...Diabetes Canada
NCT07575893
CD30 CAR-T Cells for Low Risk Relapsed Classical Hodgkin LymphomaMemorial Sloan Kettering Cancer CenterNot Yet RecruitingPhase 1
NCT07575893Not Yet Recruiting
Phase 1
CD30 CAR-T Cells for Low Risk Relapsed Classical Hodgkin LymphomaMemorial Sloan Kettering...
NCT07574541
Multitargeted Recombinant Ad5 PSA/MUC-1/Brachyury-Based Immunotherapy (TriAdeno) Vaccine With IL-15 Superagonist N-803 in Participants With Clinically Localized Prostate Cancer Undergoing Active SurveillanceNational Cancer Institute (NCI)Not Yet RecruitingPhase 2
NCT07574541Not Yet Recruiting
Phase 2
Multitargeted Recombinant Ad5 PSA/MUC-1/Brachyury-Based Immunotherapy (TriAdeno)...National Cancer Institute...
Result Breakdown
Not yet recruiting13 (65%)
Recruiting5 (25%)
Active, not recruiting1 (5%)
Completed1 (5%)
not_applicable11 (55%)
Not Specified4 (20%)
Phase 23 (15%)
Phase 12 (10%)